SCHEMBL5310540

SCHEMBL5310540

CC(=O)O[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 1/20 0.47
TDP1 Q9NUW8 2/20 0.40
TSHR P16473 2/20 0.40
MMP12 P39900 1/20 0.37
SLC22A6 Q4U2R8 1/20 0.36
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM1 P11229 1/20 0.35
TBXA2R P21731 1/20 0.35
MAPT P10636 2/20 0.34
GALR3 O60755 1/20 0.34
BLM P54132 1/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
HRH1 P35367 1/20 0.34
KMT2A Q03164 1/20 0.34
FOLH1 Q04609 1/20 0.33
MMP1 P03956 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29000852 1.00 ALOX15 (0.50) ALOX15SMN1; SMN2LMNATDP1TSHR
SCHEMBL581924 1.00 ALOX15 (0.50) ALOX15SMN1; SMN2LMNATDP1TSHR
Hydrochloric Acid SCHEMBL10892024 0.98 ALOX15 (0.48) ALOX15SMN1; SMN2LMNATDP1TSHR
SCHEMBL18219006 0.86 ALOX15 (0.41) ALOX15SMN1; SMN2LMNATDP1TSHR
SCHEMBL18219051 0.86 ALOX15 (0.41) ALOX15SMN1; SMN2LMNATDP1TSHR
SCHEMBL18908300 0.86 ALOX15 (0.41) ALOX15SMN1; SMN2LMNATDP1TSHR
SCHEMBL1652964 0.82 ALOX15 (0.47) ALOX15SMN1; SMN2LMNATDP1TSHR
SCHEMBL6560774 0.82 ALOX15 (0.38) ALOX15SMN1; SMN2LMNATDP1TSHR
SCHEMBL6157372 0.82 ALOX15 (0.47) ALOX15SMN1; SMN2LMNATDP1TSHR
SCHEMBL5404107 0.82 ALOX15 (0.38) ALOX15SMN1; SMN2LMNATDP1SLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007035066-A1 THE METHOD OF MAKING OPTICALLY ACTIVE 3-ACYLOXY-GAMMA-BUTYROLACTONE AND OPTICALLY ACTIVE 3-HYDROXY-GAMMA-BUTYROLACTONE BY ENZYMATIC METHOD ENZYTECH, LTD. (KR) 2007-03-29 WO disclosed
US-5688946-A DIPEPTIDES FOR HYPOTENSIVE AGENTS AND CARDIOVASCULAR DISORDERS HOFFMANN LA ROCHE INC. (US) 1997-11-18 US disclosed
EP-0313379-A2 Optically active compound having delta-valerolactone ring and liquid crystal composition comprising same MITSUBISHI RAYON CO., LTD. (JP) 1989-04-26 EP disclosed